These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

401 related items for PubMed ID: 23229803

  • 21. ZD1839 (Iressa) modifies the activity of key enzymes linked to fluoropyrimidine activity: rational basis for a new combination therapy with capecitabine.
    Magné N, Fischel JL, Dubreuil A, Formento P, Ciccolini J, Formento JL, Tiffon C, Renée N, Marchetti S, Etienne MC, Milano G.
    Clin Cancer Res; 2003 Oct 15; 9(13):4735-42. PubMed ID: 14581344
    [Abstract] [Full Text] [Related]

  • 22. Thymidylate synthase, dihydropyrimidine dehydrogenase, orotate phosphoribosyltransferase mRNA and protein expression levels in solid tumors in large scale population analysis.
    Fukui Y, Oka T, Nagayama S, Danenberg PV, Danenberg KD, Fukushima M.
    Int J Mol Med; 2008 Dec 15; 22(6):709-16. PubMed ID: 19020767
    [Abstract] [Full Text] [Related]

  • 23. Thymidine phosphorylase mRNA level predicts survival of patients with advanced oropharyngeal cancer.
    Ijuin T, Nibu K, Doi K, Inoue H, Saitoh M, Ohtsuki N, Makino K, Amatsu M.
    Acta Otolaryngol; 2007 Mar 15; 127(3):305-11. PubMed ID: 17364369
    [Abstract] [Full Text] [Related]

  • 24. Inhibition of EGFR phosphorylation in a panel of human breast cancer cells correlates with synergistic interactions between gefitinib and 5'-DFUR, the bioactive metabolite of Xeloda.
    Ait-Tihyaty M, Rachid Z, Mihalcioiu C, Jean-Claude BJ.
    Breast Cancer Res Treat; 2012 May 15; 133(1):217-26. PubMed ID: 21915635
    [Abstract] [Full Text] [Related]

  • 25. Factors predicting the response to oral fluoropyrimidine drugs: a phase II trial on the individualization of postoperative adjuvant chemotherapy using oral fluorinated pyrimidines in stage III colorectal cancer treated by curative resection (ACT-01 Study).
    Mori T, Ohue M, Takii Y, Hashizume T, Kato T, Kotake K, Sato T, Tango T.
    Oncol Rep; 2013 Feb 15; 29(2):437-44. PubMed ID: 23232805
    [Abstract] [Full Text] [Related]

  • 26. Phase II study of capecitabine with concomitant radiotherapy for patients with locally advanced pancreatic cancer: up-regulation of thymidine phosphorylase.
    Saif MW, Black G, Roy S, Bell D, Russo S, Eloubeidi MA, Steg A, Johnson MR, Zelterman D, Diasio RB.
    Cancer J; 2007 Feb 15; 13(4):247-56. PubMed ID: 17762760
    [Abstract] [Full Text] [Related]

  • 27. [Prediction of sensitivity to 5-fluorouracil (5-fu) by metabolic and target enzyme activities in colon cancer].
    Yamada T, Tanaka N, Yokoi K, Ishikawa N, Seya T, Horiba K, Kanazawa Y, Shirakawa T, Ohkawa K, Kudoh H, Koizumi M, Yoshioka M, Shinji S, Yamashita K, Tajiri T.
    Gan To Kagaku Ryoho; 2006 Nov 15; 33(11):1603-9. PubMed ID: 17108726
    [Abstract] [Full Text] [Related]

  • 28. Prognostication of pancreatic adenocarcinoma by expression of thymidine phosphorylase/dihydropyrimidine dehydrogenase ratio and its correlation with survival.
    Saif MW, Hashmi S, Bell D, Diasio RB.
    Expert Opin Drug Saf; 2009 Sep 15; 8(5):507-14. PubMed ID: 19663627
    [Abstract] [Full Text] [Related]

  • 29. Correlation of thymidylate synthase, thymidine phosphorylase and dihydropyrimidine dehydrogenase with sensitivity of gastrointestinal cancer cells to 5-fluorouracil and 5-fluoro-2'-deoxyuridine.
    Ma T, Zhu ZG, Ji YB, Zhang Y, Yu YY, Liu BY, Yin HR, Lin YZ.
    World J Gastroenterol; 2004 Jan 15; 10(2):172-6. PubMed ID: 14716816
    [Abstract] [Full Text] [Related]

  • 30. Relationship between gene expression of 5-fluorouracil metabolic enzymes and 5-fluorouracil sensitivity in primary cancer cells isolated from malignant ascites.
    Wang T, Wang L, Qian X, Yu L, Ding Y, Liu B.
    Cancer Invest; 2011 Feb 15; 29(2):130-6. PubMed ID: 21210725
    [Abstract] [Full Text] [Related]

  • 31. Gene expression profile of 5-fluorouracil metabolic enzymes in primary colorectal cancer: potential as predictive parameters for response to fluorouracil-based chemotherapy.
    Kinoshita M, Kodera Y, Hibi K, Nakayama G, Inoue T, Ohashi N, Ito Y, Koike M, Fujiwara M, Nakao A.
    Anticancer Res; 2007 Feb 15; 27(2):851-6. PubMed ID: 17465211
    [Abstract] [Full Text] [Related]

  • 32. The effect of chemotherapy or radiotherapy on thymidine phosphorylase and dihydropyrimidine dehydrogenase expression in cancer of the uterine cervix.
    Hasegawa K, Okamoto H, Kawamura K, Kato R, Kobayashi Y, Sekiya T, Udagawa Y.
    Eur J Obstet Gynecol Reprod Biol; 2012 Jul 15; 163(1):67-70. PubMed ID: 22480411
    [Abstract] [Full Text] [Related]

  • 33. Antitumor activity of erlotinib in combination with capecitabine in human tumor xenograft models.
    Ouchi KF, Yanagisawa M, Sekiguchi F, Tanaka Y.
    Cancer Chemother Pharmacol; 2006 May 15; 57(5):693-702. PubMed ID: 16362295
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Induction of thymidine phosphorylase in both irradiated and shielded, contralateral human U87MG glioma xenografts: implications for a dual modality treatment using capecitabine and irradiation.
    Blanquicett C, Gillespie GY, Nabors LB, Miller CR, Bharara S, Buchsbaum DJ, Diasio RB, Johnson MR.
    Mol Cancer Ther; 2002 Oct 15; 1(12):1139-45. PubMed ID: 12481438
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.